Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.

Bristol-Myers Squibb

Home/Tag:Bristol-Myers Squibb
1 12, 2015

More about elotuzumab (Empliciti). Are immunotherapies the answer?

Tags: , , , , , |0 Comments

In my haste to get the news out about elotuzumab's FDA approval yesterday, I mistakenly relied on a Cure Magazine article that stated Kyprolis was the drug used in combination with elo. I was surprised, but ran with it. I should have known better. The Cure Magazine article was mistaken. Elotuzumab (Empliciti), Revlimid and dexamethasone

7 10, 2015

Immunotherapy angst: Why is myeloma code so tough to crack?

Tags: , , |2 Comments

We were all so excited! Dying myeloma patient, Stacy from Minnesota, responded miraculously to Mayo Clinic's experimental measles vaccine therapy. Yet apparently attempts to match this early success is fleeting. U.S. News and World Report ran an excellent update yesterday about how researchers are mobilizing patient's immune systems to fight their cancer. The ongoing Mayo

3 06, 2015

ASCO News: 11;14 translocation data and elotuzumab results underwhelming

Tags: , , , , |2 Comments

I'm still hoping for some significant myeloma related data to emerge as the American Society of Clinical Oncology (ASCO) meetings wide down in Chicago.  In the meantime, the Myeloma Beacon did a nice job reviewing several poster studies which focused on my genetic abnormality: an 11;14 translocation I developed after my first stem cell transplant.

14 04, 2012

Another new myeloma antibody continues to impress…

Tags: , , , , |14 Comments

Here is some follow-up on a more well tested anti-myeloma antibody, Elotuzumab--the kind of therapy you will find featured in my new myeloma therapies book. A number of top myeloma experts, including Doctors Jakubowiak, Jagannath, Durie and Orlowski are big fans. This article is from an online trade publication called Elotuzumab Responses High in